Peripheral Neuropathy and cannabis in Florida
The state currently does not list this condition as qualifying, and the program does not provide open-ended physician discretion to add conditions. Verify with the state regulator, because programs change.
- ✗ No
- LEGAL
- 2.5 oz smokable per 35-…
- POSSESSION
- $75/yr
- STATE FEE
- 7–14 d
- TIMELINE
Florida statute and program
The Florida Medical Marijuana Use Registry is the operating authority for Florida patient certification. The authoritative legal text is: Florida Statute 381.986: Medical use of marijuana. The program portal is at Florida Medical Marijuana Use Registry.
What the evidence says about cannabis and Peripheral Neuropathy
Peripheral neuropathy is damage to or dysfunction of the peripheral nervous system (nerves outside the brain and spinal cord). Common causes include diabetes mellitus, chemotherapy, HIV infection, alcohol use, autoimmune disease, vitamin deficiency, infection, trauma, and inherited disorders. Symptoms typically include burning or shooting pain, tingling, numbness, weakness, and loss of coordination, most often in a stocking-glove distribution affecting feet first and then hands.
For the full evidence base, including the NASEM tier, randomized trial summaries, and symptom-domain breakdown, read the mmjnow Peripheral Neuropathy page.
How to qualify in Florida
The Florida Medical Marijuana Use Registry requires the following registration steps for a Peripheral Neuropathy patient (or any qualifying diagnosis):
- See an OMMU-registered qualified physician. A Florida-licensed MD or DO who has completed the Office of Medical Marijuana Use (OMMU) qualified-physician training and registered with OMMU may evaluate the patient under §381.986. The physician must establish residency in Florida for the patient (Florida driver license or state ID, plus utility bill or comparable documentation for seasonal residents) and must certify one of the ten enumerated conditions or a "comparable class" diagnosis.
- Physician submits certification to the OMMU registry. The qualified physician enters the patient certification into the OMMU Medical Marijuana Use Registry electronically. Once entered, the registry generates an application number that the patient uses for the next step. Patients may not self-register before physician entry.
- Complete the patient application and pay the $75 state fee. The patient logs into the OMMU registry with the application number, uploads a passport-style photograph and Florida driver license or state ID, and pays the $75 annual state ID card fee. Caregivers are registered through the same registry for the same fee and must pass a Level 2 background check.
- Receive the OMMU ID card and purchase from an MMTC. Florida medical marijuana use cards arrive by mail within roughly 10 business days of complete application. Patients may purchase up to 2.5 ounces of smokable cannabis per 35-day supply window and a 70-day supply of non-smokable forms from any of Florida’s licensed Medical Marijuana Treatment Centers (MMTCs). Cards renew annually with a new physician visit and a new $75 fee. Florida does not honor out-of-state medical cards; seasonal residents apply through the same OMMU process.
- State registration fee
- $75
- Physician visit (typical)
- $150–$300
- Certification to card
- 7–14 days
- Out-of-state patients
- Not eligible
- Minors
- Eligible with caregiver
For full Florida registration steps, fees, and reciprocity rules, see the Florida cannabis-laws page.
ICD-10 code
A certifying physician documenting Peripheral Neuropathy for the Florida medical cannabis program will typically record ICD-10 G62.9 or SNOMED-CT 42658009 in the patient's record. The state registry does not itself collect ICD-10 codes in most programs, but the physician's chart is the audit trail if the certification is later reviewed.
Frequently asked questions
Does Florida list Peripheral Neuropathy as a qualifying condition for medical cannabis?
No. Florida's qualifying-condition list does not currently include Peripheral Neuropathy, and the state's program does not give physicians open-ended discretion to add conditions outside the list. Patients with Peripheral Neuropathy in Florida have limited in-state pathways under the medical program as written. Options to verify and pursue include: petitioning the state regulator to add the condition (where the statute permits public petitions); consulting a physician about whether a co-occurring listed condition could support certification; or reviewing whether the state's program is undergoing legislative expansion. Florida program rules change, so verify the current list with the regulator before drawing a final conclusion.
How do I get a Florida medical marijuana card for Peripheral Neuropathy?
Because Florida does not currently list Peripheral Neuropathy as a qualifying condition, a card for Peripheral Neuropathy alone may not be obtainable in-state under the program rules as written. Step one is finding a physician licensed in Florida who is registered with Florida Medical Marijuana Use Registry and willing to evaluate Peripheral Neuropathy cases. Step two is collecting your records (diagnosis documentation, treatment history, and the ICD-10 code your physician will use) and bringing them to the certification visit. Step three is the physician's certification through the state registry, followed by the patient registration application, state fee, and waiting period before the card is issued. Florida does not honor out-of-state cards, so the certification process has to originate inside the state. The state minimum patient age is 18; minors generally require a parent or legal guardian to act as caregiver. The authoritative source for the current process is the Florida Medical Marijuana Use Registry site at https://knowthefactsmmj.com/; the state updates fees, forms, and physician registration rules periodically.
What does the evidence say about cannabis for Peripheral Neuropathy?
For Peripheral Neuropathy, evidence is described as moderate (supportive controlled studies exist but the picture is mixed). The mmjnow condition page for Peripheral Neuropathy lays out the current evidence base, including the citations underlying that evidence tier — typically the National Academies of Sciences, Engineering, and Medicine consensus reports, federal agency guidance, and peer-reviewed reviews. Evidence quality is independent of state law: a state can list a condition for which evidence is limited, and a state can decline to list a condition for which evidence is strong. Patients deciding whether to pursue medical cannabis for Peripheral Neuropathy should review the underlying evidence (linked on the condition page) and discuss expected benefit, dosing, and risk with a clinician familiar with both Peripheral Neuropathy and cannabinoid pharmacology. Cannabis is not a substitute for evidence-based first-line treatments for Peripheral Neuropathy; the evidence position above describes whether trial data supports its use, not whether it should replace standard care.
Sources
- Florida Statute 381.986: Medical use of marijuanaaccessed May 15, 2026
- Florida Office of Medical Marijuana Use (OMMU)accessed May 15, 2026
- NORML: Florida Laws & Penaltiesaccessed May 15, 2026
- Marijuana Policy Project: Floridaaccessed May 15, 2026
- Florida Statute §893.13: Prohibited acts; penalties (controlled substances)accessed May 17, 2026
- Florida Statute §322.055: Revocation/suspension of driver license for drug convictionsaccessed May 17, 2026
- NORML: Florida — Local Decriminalization Ordinancesaccessed May 17, 2026
- Miami-Dade County Code of Ordinances (Municode) — civil-citation ordinance 15-138 (2015)accessed May 17, 2026
- City of Tampa Code of Ordinances (Municode) — ordinance 2016-46accessed May 17, 2026
- City of Orlando Code of Ordinances (Municode) — ordinance 2016-29accessed May 17, 2026
- NASEM: The Health Effects of Cannabis and Cannabinoids (2017)accessed May 16, 2026
“Substantial evidence that cannabis is an effective treatment for chronic pain in adults.”
- NIH NINDS: Peripheral Neuropathyaccessed May 16, 2026